Inventor · disambiguated record
Vera Cavalli
Also filed as: CAVALLI VERA
5 granted patents·36 pending applications·5 citations·filing 2008–2008
67Inventor score
Top patents by PatentIndex Score
41 records- 0170US8349805B2Use of Gonadorelin as a therapeutic agentMONDOBIOTECH LAB AG·Filed 2008·Granted Jan 8, 2013·3 cites·4 claims
- 0270US2010190713A1Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0370US2010184708A1Use of gly-pro-glu-oh (gpe) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0470US2010234306A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0570US2010197585A1Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0670US2010184698A1Use of a deslorelin and mastoparan as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 0768US8211856B2Use of somatostatin-14 as a therapeutic agentBEVEC DORIAN·Filed 2008·Granted Jul 3, 2012·1 cites·3 claims
- 0868US8193149B2Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicineBEVEC DORIAN·Filed 2008·Granted Jun 5, 2012·1 cites·4 claims
- 0965US2010210553A1Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-arg as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1063US2010210532A1Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1163US2010210558A1Minigastrin as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1263US2010184677A1Use of the human pancreatic polypeptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1363US2010190716A1Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1463US2010273701A1Use of salusin beta alone or in combination with octreotide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1563US2010190711A1Big gastrin i as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1663US2010210536A1Use of leptin (22-56 ) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1763US2010197601A1Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infectionBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1863US2010197608A1Use of melanotrophin-potentiating factor as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 1962US2010197603A1Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infectionsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2062US2010190724A1Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infectionDORIAN BEVEC·Filed 2008·Application pending·0 cites
- 2162US2010204112A1Use of tyr-w-mif-1 and urocortin 2 as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2262US2010216724A1Use of fibronectin fragment (196-203 ) as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2360US2010204116A1Use of calcitonin as anti-angiogenic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2460US2010197605A1Therapeutic use of peptide yglf and combination with kvlpvpqBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2560US2010197586A1Use of secretin and optionally urodilatin as therapeutic agentsBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2660US2010184674A1Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2760US2010197599A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2860US2010204152A1Use of gluten exorphin c : as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 2960US2010197587A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3060US2010197588A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3160US2010184676A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3260US2010256043A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3358US2010210561A1Use of peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3458US2010210539A1Use of peptide ll-37 as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3558US2010292132A1Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3657US2010184678A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3757US2010216722A1Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 3854US8541364B2Use of a octreotide as a therapeutic agentBEVEC DORIAN·Filed 2008·Granted Sep 24, 2013·0 cites·3 claims
- 3954US8338380B2Use of the peptide RFMWMR as a therapeutic agentBEVEC DORIAN·Filed 2008·Granted Dec 25, 2012·0 cites·3 claims
- 4046US2010204129A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
- 4146US2010249019A1Use of a peptide as a therapeutic agentBEVEC DORIAN·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vera Cavalli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →